Deutsche Bank’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.41M Sell
386,938
-9,870
-2% -$138K ﹤0.01% 1201
2025
Q1
$5.35M Sell
396,808
-6,066
-2% -$81.8K ﹤0.01% 1221
2024
Q4
$7.72M Buy
402,874
+23,327
+6% +$447K ﹤0.01% 1123
2024
Q3
$8.63M Buy
379,547
+331,102
+683% +$7.53M ﹤0.01% 1056
2024
Q2
$630K Buy
48,445
+1,672
+4% +$21.8K ﹤0.01% 2193
2024
Q1
$819K Buy
46,773
+3,982
+9% +$69.7K ﹤0.01% 2072
2023
Q4
$932K Buy
42,791
+20,768
+94% +$452K ﹤0.01% 2031
2023
Q3
$338K Sell
22,023
-70,631
-76% -$1.08M ﹤0.01% 2408
2023
Q2
$2.2M Sell
92,654
-161,460
-64% -$3.84M ﹤0.01% 1574
2023
Q1
$6.46M Buy
254,114
+237,028
+1,387% +$6.03M ﹤0.01% 1124
2022
Q4
$499K Buy
17,086
+6,005
+54% +$175K ﹤0.01% 2446
2022
Q3
$227K Sell
11,081
-1,687
-13% -$34.6K ﹤0.01% 2857
2022
Q2
$148K Buy
+12,768
New +$148K ﹤0.01% 3308
2020
Q1
Sell
-1,424
Closed -$10K 4542
2019
Q4
$10K Sell
1,424
-1,212
-46% -$8.51K ﹤0.01% 4285
2019
Q3
$28K Sell
2,636
-7,569
-74% -$80.4K ﹤0.01% 4048
2019
Q2
$313K Sell
10,205
-1,624
-14% -$49.8K ﹤0.01% 3510
2019
Q1
$494K Sell
11,829
-881
-7% -$36.8K ﹤0.01% 3411
2018
Q4
$577K Buy
12,710
+8,786
+224% +$399K ﹤0.01% 3197
2018
Q3
$328K Buy
3,924
+654
+20% +$54.7K ﹤0.01% 3926
2018
Q2
$315K Sell
3,270
-350
-10% -$33.7K ﹤0.01% 3988
2018
Q1
$380K Sell
3,620
-441
-11% -$46.3K ﹤0.01% 3787
2017
Q4
$634K Buy
4,061
+3,305
+437% +$516K ﹤0.01% 3407
2017
Q3
$102K Sell
756
-209
-22% -$28.2K ﹤0.01% 3964
2017
Q2
$185K Buy
+965
New +$185K ﹤0.01% 3816
2017
Q1
Sell
-71
Closed -$5K 4541
2016
Q4
$5K Buy
+71
New +$5K ﹤0.01% 4328